Home Cart Sign in  
Chemical Structure| 372196-77-5 Chemical Structure| 372196-77-5

Structure of PIK-75 HCl
CAS No.: 372196-77-5

Chemical Structure| 372196-77-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PIK-75 is a selective p110α inhibitor with IC50 of 5.8 nM with 200-fold more potently than p110β, and also potently inhibits DNA-PK with IC50 of 2 nM.

Synonyms: PIK-75; PIK-75 (hydrochloride); PIK-75 hydrochloride

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PIK-75 HCl

CAS No. :372196-77-5
Formula : C16H15BrClN5O4S
M.W : 488.74
SMILES Code : BrC(C=C1)=CN2C1=NC=C2/C=N/N(S(=O)(C3=C(C=CC([N+]([O-])=O)=C3)C)=O)C.[H]Cl
Synonyms :
PIK-75; PIK-75 (hydrochloride); PIK-75 hydrochloride
MDL No. :MFCD12546130

Safety of PIK-75 HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of PIK-75 HCl

DNA
PI3K-AKT

Isoform Comparison

Biological Activity

Description
PIK-75 hydrochloride is a reversible inhibitor selectively targeting DNA-PK and p110α, with IC50 values of 2, 5.8, and 76 nM for DNA-PK, p110α, and p110γ, respectively. Notably, PIK-75 hydrochloride exhibits over 200-fold greater potency against p110α compared to p110β (IC50=1.3 μM)[1][2].
Target
  • p110γ

    p110γ, IC50:76 nM

  • p110α

    p110α, IC50:5.8 nM

  • p110δ

    p110δ, IC50:0.51 μM

  • DNA-PK

    DNA-PK, IC50:2 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
HeLa cells 100 nM 1 hour PIK-75 profoundly increased TRAIL sensitivity of HeLa cells PMC3921597
A549 cells 200 nM 1 hour PIK-75 sensitized A549 cells to apoptosis induction by TRAIL PMC3921597
MTLn3 ErbB3WT cells 200 nM PIK-75 significantly inhibited the chemotactic response of MTLn3 ErbB3WT cells to HRG β1 PMC3469325
LN229 0.5 μM 24 hours PIK-75 induced G2M arrest and apoptosis (increase in sub-G1 fraction). PMC3411950
U87 0.5 μM 24 hours PIK-75 induced apoptosis most efficiently in PTEN wild-type cells, but less effectively in PTEN mutant cells. PMC3411950
LN229 PTENWT 0.5 μM 24 hours Apoptosis induced by PIK-75 was partially attenuated by the PTEN inhibitor bpv, but G2M arrest remained unaffected. PMC3411950
LN229 1 μM 24 hours Knockdown of Bax reduced PIK-75-induced PARP cleavage and apoptosis. PMC3411950
AsPC-1 cells 0.1 µM 24 hours PIK-75 significantly reduced the ARE-Luc activity in AsPC-1 cells, indicating its inhibition of NRF2-dependent transcription. PMC3928470
MIA PaCa-2 cells 0.1 µM 48 hours PIK-75 inhibited the proliferation of MIA PaCa-2 cells, indicating its suppression of pancreatic cancer cell growth through induction of apoptosis. PMC3928470
A375M 5 µM 24 and 48 hours Screening of anti-cancer compound library to evaluate cell vitality and proliferation. PIK-75 was shown as the most effective drug and had a synergistic effect with miR-126. PMC6717748
A375M-VR 0.5 µM 5 hours Evaluation of PIK-75's effect on resistant cell lines, showing significant induction of apoptosis. PMC6717748

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
mice orthotopic lung cancer xenograft model intraperitoneal injection 50 mg/kg once daily for 32 days Combination of TRAIL and SNS-032 significantly inhibited tumor growth in the orthotopic lung cancer xenograft model PMC3921597
Mice ErbB3WT tumor model Intraperitoneal injection 7 mg/kg Twice a week for 4 weeks PIK-75 significantly inhibited in vivo motility and invasion of ErbB3WT tumor cells PMC3469325
Nude mice GBM43 xenograft model Intraperitoneal injection 30 mg/kg SNS-032 4 consecutive days Combination therapy with PIK-90 and roscovitine significantly reduced tumor volume and induced apoptosis. PMC3411950
nude mice MIA PaCa-2 xenograft model intraperitoneal injection 100 mg/kg/day and 200 mg/kg/day Once daily for 64 weeks The combination of PIK-75 and gemcitabine significantly inhibited tumor growth without affecting the body weights of mice. PMC3928470
Nude mice Mouse xenograft model Intraperitoneal injection 15 μM Evaluation of the synergistic role of miR-126 in combination with PIK-75 and/or vemurafenib, showing significant tumor growth inhibition and apoptosis induction. PMC6717748

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.05mL

0.41mL

0.20mL

10.23mL

2.05mL

1.02mL

20.46mL

4.09mL

2.05mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories